Richard Pellegrino Is Appointed New Chief Research and Development Officer of Grenova

Grenova, Inc., a Virginia-based designer, manufacturer, and distributor of instruments and associated consumables for the life sciences industry, today announced the appointment of Richard Pellegrino as Chief Research and Development Officer.

Richard Pellegrino joins Grenova during a period of rapid growth as the company expands its award-winning team designed to make the life sciences industry environmentally friendly, cost-effective, and efficient.

“From the bench to the board room, Richard has an unmatched reputation for leading high-performing research and development teams throughout his impressive career,” said Lane Major, President and Chief Executive Officer of Grenova. “Richard will make an immediate impact as Grenova continues to grow its team of industry leaders committed to proprietary technology that is providing a unique economic, environmental, and supply chain value proposition to our customers around the world.”

Pellegrino brings decades of experience in research and development, as well as a steadfast commitment to innovation, to Grenova having served as a key member of executive teams and an R&D subject matter expert for startup, mid-sized, and Fortune 500 businesses. He has shepherded organizations through all stages of growth — from raising $9M in venture capital to found Relievant Medsystems, to leading an R&D team through an IPO and integrating them into the fabric of Stryker’s Spine Division following the $1.4B acquisition of K2M, Inc. Pellegrino also serves as an Entrepreneur in Residence (EIR) for the VCU tech transfer group and is a named inventor on more than 60 issued patents.

“I was inspired to join Grenova because it’s a first-to-market innovator that has created technology capable of transforming the entire life sciences industry and beyond,” said Pellegrino. “Driven by radical innovation and a constant pursuit of new ideas, Grenova’s products are creating a more sustainable future while lowering costs in the laboratory industry and increasing efficiencies as its impact is felt across the globe.”

SourceGrenova

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.